Daniela Damiani

17PUBLICATIONS
15CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 13, 2025
New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers.

Giulia Battaglia, Davide Lazzarotto, Ilaria Tanasi

|Jan 08, 2025
Advancing Chimeric Antigen Receptor T-Cell Therapy for Acute Myeloid Leukemia: Current Limitations and Emerging Strategies.

Daniela Damiani, Mario Tiribelli

|Jun 27, 2024
CAR-T Cells in Acute Myeloid Leukemia: Where Do We Stand?

Daniela Damiani, Mario Tiribelli

|Jan 23, 2024
ATP-Binding Cassette Subfamily G Member 2 in Acute Myeloid Leukemia: A New Molecular Target?

Daniela Damiani, Mario Tiribelli

|Jun 28, 2023
Checkpoint Inhibitors in Acute Myeloid Leukemia.

Daniela Damiani, Mario Tiribelli

|Apr 28, 2023
ABCG2 in Acute Myeloid Leukemia: Old and New Perspectives.

Daniela Damiani, Mario Tiribelli

Pageof 3

Frequent Collaborators

13 joint publications

Mario Tiribelli

2 joint publications

Massimiliano Bonifacio

1 joint publications

Haifa Kathrin Al-Ali

1 joint publications

Martin Griesshammer